Surgical Tissue Adhesive Market
The market for Surgical Tissue Adhesive was estimated at $656 million in 2024; it is anticipated to increase to $884 million by 2030, with projections indicating growth to around $1.13 billion by 2035.
Global Surgical Tissue Adhesive Market Outlook
Revenue, 2024
Forecast, 2034
CAGR, 2025 - 2034
The Surgical Tissue Adhesive industry revenue is expected to be around $689.6 million in 2025 and expected to showcase growth with 5.1% CAGR between 2025 and 2034. The increasing importance of Surgical Tissue Adhesive in healthcare is highlighted by the projected numbers-a consequence of various influential factors at play. The adhesives remarkable ability to expedite and ensure wound closure holds significant value in addressing post surgery issues satisfactorily. Factors such as its rising acceptance among professionals and the aging population along with advancements in surgical practices contribute substantially towards its continued significance and utilization, in the worldwide market.
The Surgical Tissue Adhesive, also known as Skin Glue, is a biocompatible glue commonly employed in surgical procedures for closing wounds efficiently and securely instead of using traditional stitching techniques. Due, to its ability to bond tissues effectively while allowing flexibility and strength which aid in quick healing and lower infection risks. This adhesive is widely utilized across medical specialties including orthopaedic navigation, dental surgery, cosmetic surgery, cardiovascular surgery and other related fields.
Market Key Insights
The Surgical Tissue Adhesive market is projected to grow from $656.1 million in 2024 to $1.08 billion in 2034. This represents a CAGR of 5.1%, reflecting rising demand across Wound Care & Closure, Surgical Hemostasis, and Tissue Sealing.
Johnson & Johnson, 3M Company, Baxter International Inc. are among the leading players in this market, shaping its competitive landscape.
U.S. and Germany are the top markets within the Surgical Tissue Adhesive market and are expected to observe the growth CAGR of 3.3% to 4.9% between 2024 and 2030.
Emerging markets including Indonesia, Brazil and South Africa are expected to observe highest growth with CAGR ranging between 5.9% to 7.0%.
Transition like The Rise of Biodegradable Surgical Tissue Adhesives has greater influence in U.S. and Germany market's value chain; and is expected to add $23 million of additional value to Surgical Tissue Adhesive industry revenue by 2030.
The Surgical Tissue Adhesive market is set to add $423 million between 2024 and 2034, with manufacturer targeting Wound Closure & Sealing Application projected to gain a larger market share.
With
rising incidences of surgeries, and
Technological Advancements, Surgical Tissue Adhesive market to expand 64% between 2024 and 2034.
Opportunities in the Surgical Tissue Adhesive
Growth Opportunities in North America and Asia Pacific
Market Dynamics and Supply Chain
Driver: Rising Incidences of Surgeries, and Rising Preference for Minimally Invasive Procedures
Restraint: Regulatory Hurdles
Opportunity: Strategic Collaborations to Bolster Market Presence and Technological Innovations Driving Adoption
Challenge: Market Acceptance
Supply Chain Landscape
Raw Material Providers
Adhesive Formulation Manufacturers
Packaging & Distribution
End Users
Raw Material Providers
Adhesive Formulation Manufacturers
Packaging & Distribution
End Users
Use Cases of Surgical Tissue Adhesive in Wound Care & Closure & Sealing
Recent Developments
The Skin Glue market has undergone changes due in part by advancements in medical technology and the growing preference for minimally invasive procedures. Surgical tissue adhesives have emerged as a factor in this transformation by providing an efficient substitute, for conventional sutures and staples.